Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer/BioNTech Combo Vaccine Shows Partial Flu Efficacy

Setback Could Benefit Moderna

16 Aug 2024

• By Alaric DeArment

• Source: Shutterstock

Related Content

Moderna Marches Into Phase III With COVID/Flu Vaccine Combo

05 Oct 2023

Moderna Pips Pfizer/BioNTech In Combo Jab Race

10 Jun 2024

Moderna And GSK Hit By Declining RSV Vaccines Expectations

28 Jun 2024

Pfizer Fires Shot Across RSV Bow With Topline Data In Younger Adults

12 Aug 2024

Related Companies

Pfizer Inc.

BioNTech SE

Sanofi

GSK plc

Additional Topics

Vaccines Coronavirus COVID-19 Clinical Trials Research & Development BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.